{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:16:38Z","timestamp":1783138598247,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-18-IBHU-0002"],"award-info":[{"award-number":["ANR-18-IBHU-0002"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejca.2026.116768","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:23:15Z","timestamp":1777674195000},"page":"116768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6118-5768","authenticated-orcid":false,"given":"Victor","family":"Robic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2694-926X","authenticated-orcid":false,"given":"Jules","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2208-0834","authenticated-orcid":false,"given":"Ghina","family":"Jardali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-3936","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Choucair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Dawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Littisha","family":"Lawrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2053-8639","authenticated-orcid":false,"given":"Vincent","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Smolenschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6591-2213","authenticated-orcid":false,"given":"Thomas","family":"Pudlarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine M.","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-6911","authenticated-orcid":false,"given":"Marine","family":"Valery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-4663","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Boige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3804-3554","authenticated-orcid":false,"given":"Anthony","family":"Tarabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Boil\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lassau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2026.116768_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ejca.2026.116768_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ije\/dyx088","article-title":"Focus on an unusual rise in pancreatic cancer incidence in France","volume":"46","author":"Bouvier","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2026.116768_bib5","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"23","key":"10.1016\/j.ejca.2026.116768_bib6","first-page":"00824","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2020","volume":"7534","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116768_bib7","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3389\/fonc.2020.01466","article-title":"Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116768_bib8","article-title":"Precision medicine strategy in pancreatic ductal adenocarcinoma","volume":"10","author":"Tarabay","year":"2025","journal-title":"ESMO Open D\u00e9C"},{"issue":"4","key":"10.1016\/j.ejca.2026.116768_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial","volume":"21","author":"Pishvaian","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116768_bib10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","article-title":"Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer","volume":"16","author":"Rolfo","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116768_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br J Cancer janv"},{"issue":"8","key":"10.1016\/j.ejca.2026.116768_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","article-title":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group","volume":"33","author":"Pascual","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116768_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: A broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2026.116768_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102728","article-title":"Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer","volume":"54","author":"Kohli","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.annonc.2022.09.163","article-title":"Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study","volume":"34","author":"Reichert","year":"2023","journal-title":"Ann Oncol"},{"issue":"3_","key":"10.1016\/j.ejca.2026.116768_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1200\/JCO.2024.42.3_suppl.621","article-title":"Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer","volume":"42","author":"Pathak","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12029-024-01129-0","article-title":"The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer","volume":"56","author":"Cox","year":"2025","journal-title":"J Gastrointest Cancer 14 janv"},{"issue":"5","key":"10.1016\/j.ejca.2026.116768_bib18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.32586","article-title":"Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma","volume":"146","author":"Strijker","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2026.116768_bib19","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232674","article-title":"Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases","volume":"313","author":"Dawi","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2026.116768_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114020","article-title":"Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients","volume":"202","author":"Barbe","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116768_bib21","unstructured":"Belkouchi Y. Machine learning for the identification of image-based biomarkers for immunotherapy efficiency on CT and US imaging modalities [phd]. [City, Country]: Universit\u00e9 Paris-Saclay; 2024. https:\/\/theses.fr\/2024UPASG006."},{"issue":"4","key":"10.1016\/j.ejca.2026.116768_bib22","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/cimb46040177","article-title":"Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer","volume":"46","author":"Stefanoudakis","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.ejca.2026.116768_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116160","article-title":"Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment","volume":"232","author":"Debiais","year":"2026","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2026.116768_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.116768_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinimag.2024.110365","article-title":"Role of volumetric tumor enhancement on CT in predicting overall survival in patients with unresectable pancreatic ductal adenocarcinoma","volume":"117","author":"Madani","year":"2025","journal-title":"Clin Imaging"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-13160-7","article-title":"Correlation between circulating tumor DNA quantity assessed by methylated markers and tumor volume in patients with metastatic pancreatic adenocarcinoma","volume":"15","author":"Caliez","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ejca.2026.116768_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diii.2025.06.002","article-title":"Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer","volume":"106","author":"Jardali","year":"2025","journal-title":"Diagn Inter Imaging"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2018.09.022","article-title":"Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer","volume":"156","author":"Bernard","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ejca.2026.116768_bib29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","article-title":"High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants","volume":"25","author":"Razavi","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116768_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41698-024-00685-9","article-title":"Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials","volume":"8","author":"Bayle","year":"2024","journal-title":"NPJ Precis Oncol 7"},{"issue":"8","key":"10.1016\/j.ejca.2026.116768_bib31","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41416-023-02189-y","article-title":"Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer","volume":"128","author":"Umemoto","year":"2023","journal-title":"Br J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:23:46Z","timestamp":1783135426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"alternative-id":["S0959804926005496"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116768","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116768"}}